HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control
about
Role of HLA Adaptation in HIV EvolutionStructural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphismsSelector function of MHC I molecules is determined by protein plasticityProtective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern PolandHIV subtype influences HLA-B*07:02-associated HIV disease outcome.PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progressionHuman leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencingCo-operative additive effects between HLA alleles in control of HIV-1Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.Full-length novel MHC class I allele discovery by next-generation sequencing: two platforms are better than oneA molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.CD8+ TCR Bias and Immunodominance in HIV-1 Infection.Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progressionDisease progression despite protective HLA expression in an HIV-infected transmission pairInterplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.HIV control through a single nucleotide on the HLA-B locus.HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?Immunogenetics of HIV disease.HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.Structure of tumor necrosis factor-alpha haploblocks in European populations.Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.Proofreading of Peptide-MHC Complexes through Dynamic Multivalent Interactions.HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-PresentationWidespread impact of HLA restriction on immune control and escape pathways of HIV-1Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape.A closer look at hepatitis C clearance in HIV controllers: a response.Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.
P2860
Q26772713-264FA2F7-D961-448A-8062-AF246C463919Q27675160-212AE876-AB58-49EB-AFBF-EB379A7F5530Q28268813-FBA9CB02-4B8D-4853-ADF4-6321FC5BDB40Q28548130-41C00F3B-9639-47AF-8E3B-E5E13B44BA0BQ33566546-303A39EC-A2F9-474B-A2D4-64B6E09EBE03Q33652856-D97D88B1-4308-480E-B961-6729DA4808AFQ33712891-94B4F761-245C-4BB5-BD33-5A2B2034A32DQ34015054-E22ADE7E-B580-4D36-A67B-ECC85EED89D7Q34367478-3A6F4EFF-3C0D-4DF0-960C-A794C16247F6Q34456570-6EC808A4-55E4-4000-A8F2-AA4FF895D058Q34490157-34456803-F2B9-4195-ADAD-4571243922CCQ34594538-090339AB-649A-4256-8754-CA8F8E7C3422Q35045019-726BA783-7549-41DA-8D5B-50F4BDA900C7Q35141000-EB3F460B-45C4-4415-8A4C-2CD2B3DD781CQ35168561-5A53307B-91A4-44C3-80EA-9B4B0356AD0FQ35613273-0C9E09EF-EB51-4504-80E1-2E787A046F5BQ35664125-3E77605B-7325-41D7-BEE1-6BCA5508A3E2Q35749934-BE826220-B5E7-4A9F-AEEA-184C61AD8DADQ35804078-0D8F2268-3F76-4BA5-8458-1F49D863D43AQ35993707-AC76444E-1F7C-4C84-8903-DF1C55CA422FQ36363448-2481132B-8249-4923-90D6-6BEE6279CF6CQ36395847-3E2B4596-4B8D-45CC-81BC-DD3500063626Q36397593-BB34984D-551C-431B-9EC7-06F995BC88FAQ36414604-6748EDC3-1AFE-44C9-9EDB-04F3EBD9C5A2Q36759787-15F9BFC2-4D01-438A-911A-E86DD522939FQ36989456-7C488B0E-0A85-4924-AC77-7D5FE7420B72Q37252948-AE47D022-FB73-4492-ABED-F3855990ADECQ37272153-87155B45-04AC-4C55-936B-06666B8DD7DBQ37631857-7EE368DF-F21E-4032-B6C6-72B70A3D95A7Q37700889-8C9054F2-845E-44F9-8D44-F56DDA9D5D64Q37714013-E39485AC-806E-484E-A4FD-5F0514C7D2BDQ38762336-2147AB12-DCB1-4E88-AB53-B5114B8EFEC9Q39147202-45048CAD-2CBE-4240-9C4B-8384DB7736C8Q40054946-7844C85D-B855-405C-AFDB-D9BFDC445C79Q40743173-C8C73E00-A9A7-4BDE-9348-45371FB0D5C4Q41814777-07203E14-9C01-4F6F-A674-D6A7354A3993Q41923263-900EF1BC-6922-41E1-9294-08E0D7EBD209Q42968583-85653B16-789D-4037-B588-33E4F16C92D4Q46500540-9472BD3E-00F0-4589-9B68-F035F6DA0570Q54233740-D62F23FF-5E77-4F0C-81A7-36D51FC43314
P2860
HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@ast
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@en
type
label
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@ast
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@en
prefLabel
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@ast
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@en
P2860
P50
P356
P1433
P1476
HLA-B*57 Micropolymorphism sha ...... essure, and HIV immune control
@en
P2093
Henrik N Kloverpris
Lynn Riddell
P2860
P304
P356
10.1128/JVI.06150-11
P407
P50
P577
2011-11-16T00:00:00Z